<DOC>
	<DOCNO>NCT01579201</DOCNO>
	<brief_summary>The purpose trial determine effective dose carbetocin would prevent occurrence postpartum uterine atony 90 % woman undergo elective cesarean delivery .</brief_summary>
	<brief_title>ED90 Determination Carbetocin Prevention Uterine Atony Women Undergoing Elective Cesarean Delivery</brief_title>
	<detailed_description>Postpartum hemorrhage major cause maternal morbidity mortality worldwide . Carbetocin show effective prevention uterine atony , lead cause postpartum hemorrhage . The Society Obstetricians Gynecologists Canada recommend single 100 mcg dose carbetocin elective cesarean delivery prevent postpartum hemorrhage . However , clear data literature regard low effective dose carbetocin administer . The use minimum effective dose carbetocin may reduce side effect , include hypotension , tachycardia , nausea , vomit flushing . In trial , healthy term pregnant woman undergo elective cesarean delivery spinal anesthesia recruit . The effective dose carbetocin prevent postpartum uterine atony 90 % woman ( ED90 ) determine use bias coin design up-down sequential allocation method . The determination carbetocin ED90 help anesthesiologist regard optimal dose carbetocin administer elective cesarean delivery prevent uterine atony .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Uterine Inertia</mesh_term>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Healthy pregnant woman ( ASA I II ) Elective cesarean delivery Spinal anesthesia Term gestation ( 37 week ) Multiple gestation Known coagulopathy Active labour Uterine fibroid Body mass index &gt; 45 Emergency cesarean section General anesthesia Any contraindication neuraxial anesthesia Cardiopathies Known allergy carbetocin Patient refusal Placenta previa/Placenta accreta Hypertensive disease/Preeclampsia/Eclampsia Polyhydramnios Previous history uterine atony postpartum hemorrhage Renal liver disease</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Postpartum Hemorrhage</keyword>
	<keyword>Uterine Atony</keyword>
	<keyword>Obstetric Anesthesia</keyword>
	<keyword>Cesarean Section</keyword>
	<keyword>Carbetocin</keyword>
</DOC>